Author

Adrian Kessler

Adrian Kessler covers health science, cannabis and psychedelics for Mugglehead: the trials, the regulators and the companies they reach, with the peers, the price and the person who said it. 101 stories by Adrian Kessler.

Latest

Oct 17

Health

UCB wins FDA approval for ZILBRYSQ autoinjector ahead of 2027 launch

Oct 16

Health

Alcon wins FDA approval for BRYTLY eye drops with up to 12‑hour relief

Oct 16

Health

Opus Genetics wins FDA approval for presbyopia eye drops

Oct 16

Health

Organon reports six‑year MIUDELLA data as FDA reviews longer use

Oct 16

Technology

Li Auto signs RMB1.625B equity financing for chip subsidiary

Oct 16

Health

Edesa Biotech gains FDA clearance to expand Phase 2 vitiligo trial

Oct 15

Cannabis

Cronos Group closes €57.5M CanAdelaar acquisition in the Netherlands

Oct 15

Health

NeoGenomics expands Indica Labs partnership for digital pathology

Oct 15

Cannabis

Curaleaf relocates Gettysburg dispensary to York, keeping 18 Pennsylvania stores

Oct 15

Cannabis

Organigram Global targets C$8M to C$10M savings after Sanity integration